Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays.
about
Towards personalised therapy for von Willebrand disease: a future role for recombinant productsPT-VWD posing diagnostic and therapeutic challenges - small case series.The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.Collagen binding provides a sensitive screen for variant von Willebrand disease.Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.Making a diagnosis of VWD.Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges.Type 2M von Willebrand disease - more often misidentified than correctly identified.Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies.Potential misdiagnosis of von Willebrand disease and haemophilia caused by ineffective mixing of thawed plasma.Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.Laboratory Testing for Von Willebrand Factor Multimers.Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.Rare forms of von Willebrand diseaseMajor Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation
P2860
Q26748376-30453C97-B27A-4AD7-BA31-28941D204038Q33436573-CAB0BCB9-FDA8-41A5-900A-2F8E2483D973Q34816051-68A6B7C5-838A-46B0-A915-91A35EE98A02Q37367262-4CE2D216-2E89-4ECB-81EC-08AF6784C663Q37671400-1CA00669-6CDA-4D5D-BF03-DF4AB1B2827DQ37703427-8AA99843-8AFD-4FC1-9D06-685B9F469378Q38066864-A5A144A8-8AD6-417D-A8C4-143D5A4FA3D0Q38205952-BFD7B858-265B-47B4-8BD0-2B8F49FFEEBAQ39876587-A2F966C5-4957-4C0A-83BF-78503F2EC81CQ45867275-7FE74276-2AF5-4711-BD67-63D173E5FE25Q45870119-65505369-789D-47D2-965A-77125C9AABCFQ45877641-99ABBE90-B57E-42C6-9173-B83828BA9646Q47957531-541D2087-D685-4969-A870-CE36DDDC86BCQ49130346-64E3EBE8-5F17-4919-A842-DCCBFB30DAF9Q57300553-357E9C5B-7EA0-402C-A6D1-C41D26ABFDF0Q58481395-E53B49DC-E542-4B93-A507-F69B8F8E28F8
P2860
Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Differential sensitivity of vo ...... -binding and mAb-based assays.
@en
Differential sensitivity of vo ...... -binding and mAb-based assays.
@nl
type
label
Differential sensitivity of vo ...... -binding and mAb-based assays.
@en
Differential sensitivity of vo ...... -binding and mAb-based assays.
@nl
prefLabel
Differential sensitivity of vo ...... -binding and mAb-based assays.
@en
Differential sensitivity of vo ...... -binding and mAb-based assays.
@nl
P2093
P2860
P1476
Differential sensitivity of vo ...... -binding and mAb-based assays.
@en
P2093
D Funk Adcock
E J Favaloro
P2860
P304
P356
10.1111/J.1538-7836.2012.04729.X
P577
2012-06-01T00:00:00Z